This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. ADMA Biologics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.152. ADMA Biologics's 10-Year median PS Ratio is 5.599. Therefore, the Median PS Value for today is $6.45.
As of today (2024-04-25), ADMA Biologics's share price is $6.29. ADMA Biologics's Median PS Value is $6.45. Therefore, ADMA Biologics's Price to Median PS Value for today is 0.98.
The historical rank and industry rank for ADMA Biologics's Median PS Value or its related term are showing as below:
ADMA'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.7 Med: 0.7 Max: 1.01
Current: 0.98
During the past 13 years, the highest Price to Median PS Value of ADMA Biologics was 1.01. The lowest was 0.70. And the median was 0.70.
ADMA's Price-to-Median-PS-Value is ranked worse than 68.22% of 258
companies
in the Biotechnology industry
Industry Median: 0.66
vs ADMA: 0.98
ADMA Biologics Median PS Value Historical Data
The historical data trend for ADMA Biologics's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ADMA Biologics's Median PS Value
For the Biotechnology subindustry, ADMA Biologics's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ADMA Biologics's Price-to-Median-PS-Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ADMA Biologics's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where ADMA Biologics's Price-to-Median-PS-Value falls into.
ADMA Biologics Median PS Value Calculation
ADMA Biologics's Median PS Value for today is calculated as
10-Year Median PS Ratio is 5.599.
ADMA Biologics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.152.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADMA Biologics (NAS:ADMA) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
ADMA Biologics's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
6.29
/
6.45
=
0.98
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADMA Biologics Median PS Value Related Terms
Thank you for viewing the detailed overview of ADMA Biologics's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
ADMA Biologics (ADMA Biologics) Business Description
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ADMA has been successfully added to your 